Safety and efficacy of desmopressin (DDAVP) in preventing hematoma expansion in intracranial hemorrhage associated with antiplatelet drugs use: A systematic review and metaanalysis.

Although the observed effect did not reach statistical significance, it raises the possibility that DDAVP might influence the thrombotic risk profile in patients with antiplatelet‐associated ICH.

also in 111,027 other papers

Although the study is unable to conclusively establish DDAVP as the preferred medication for controlling AA‐ICH, the analysis of hematoma expansion, a primary outcome, showed a trend toward lower risk in the DDAVP group compared to the control group.

also in 53,322 other papers